United Kingdom · Venture startup
Funding summaryUpdated 26 Oct 2026
$32Mraised across 6 rounds since 2011, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
PfizerFrom a historical funding record
No investor was named in the report.
From a historical funding record
Autifony Therapeutics filed one raise, $784K in all. Filings say how much was sold and to how many investors; they never name the investors.
From Autifony Therapeutics's own website: 2 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Innovate UKSV Life SciencesPfizerSV Health InvestorsTechnology Strategy BoardUCL BusinessInternational Biotechnology Trust PLC (IBT)Missing a round, or an investor who was in one? Tell us.
Autifony Therapeutics's investors include Imperial Innovations Investment Management, Innovate UK, SV Life Sciences, Pfizer and SV Health Investors, and 3 more on record.
Autifony Therapeutics has raised $32M across 6 rounds since 2011.
Autifony Therapeutics's most recent round, $784K, was in Nov 2023.
Autifony Therapeutics's largest round on record is $12M (Series A), in Jul 2015.
Autifony Therapeutics's first round on record, in Aug 2011, was backed by Imperial Innovations Investment Management.
Autifony Therapeutics's latest named round is a Venture, in Mar 2017.
Autifony Therapeutics is based in the United Kingdom.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
